DE102006004111B4 - Contact lens material - Google Patents
Contact lens material Download PDFInfo
- Publication number
- DE102006004111B4 DE102006004111B4 DE102006004111.9A DE102006004111A DE102006004111B4 DE 102006004111 B4 DE102006004111 B4 DE 102006004111B4 DE 102006004111 A DE102006004111 A DE 102006004111A DE 102006004111 B4 DE102006004111 B4 DE 102006004111B4
- Authority
- DE
- Germany
- Prior art keywords
- contact lens
- lens material
- ammonium
- chloride
- material according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000463 material Substances 0.000 title claims abstract description 41
- -1 alkyl ammonium halide Chemical class 0.000 claims abstract description 16
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 claims abstract description 9
- 125000005210 alkyl ammonium group Chemical group 0.000 claims abstract description 5
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229940117986 sulfobetaine Drugs 0.000 claims abstract description 4
- 102100026735 Coagulation factor VIII Human genes 0.000 claims abstract 2
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 claims abstract 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 7
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 6
- 239000010703 silicon Substances 0.000 claims description 6
- 229910052710 silicon Inorganic materials 0.000 claims description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 5
- 239000001301 oxygen Substances 0.000 claims description 5
- 229910052760 oxygen Inorganic materials 0.000 claims description 5
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- 230000035699 permeability Effects 0.000 claims description 4
- KGFZXHNRHCVICF-UHFFFAOYSA-N 3-[2-(2-methylprop-2-enoyloxy)ethylamino]propane-1-sulfonic acid Chemical compound CC(=C)C(=O)OCCNCCCS(O)(=O)=O KGFZXHNRHCVICF-UHFFFAOYSA-N 0.000 claims description 3
- 235000019270 ammonium chloride Nutrition 0.000 claims description 3
- 150000003863 ammonium salts Chemical class 0.000 claims description 3
- 229960003237 betaine Drugs 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 150000002894 organic compounds Chemical class 0.000 claims description 2
- 230000000379 polymerizing effect Effects 0.000 abstract 1
- 210000004087 cornea Anatomy 0.000 description 16
- 239000000178 monomer Substances 0.000 description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- 239000000017 hydrogel Substances 0.000 description 9
- 229920000642 polymer Polymers 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000006116 polymerization reaction Methods 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 4
- 235000019743 Choline chloride Nutrition 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 4
- 229960003178 choline chloride Drugs 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 230000000855 fungicidal effect Effects 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 0 *C*(*)(CCC*C(C(N)=*)=O)INI Chemical compound *C*(*)(CCC*C(C(N)=*)=O)INI 0.000 description 2
- AVTLBBWTUPQRAY-UHFFFAOYSA-N 2-(2-cyanobutan-2-yldiazenyl)-2-methylbutanenitrile Chemical compound CCC(C)(C#N)N=NC(C)(CC)C#N AVTLBBWTUPQRAY-UHFFFAOYSA-N 0.000 description 2
- GNSFRPWPOGYVLO-UHFFFAOYSA-N 3-hydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCO GNSFRPWPOGYVLO-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- GDFCSMCGLZFNFY-UHFFFAOYSA-N Dimethylaminopropyl Methacrylamide Chemical compound CN(C)CCCNC(=O)C(C)=C GDFCSMCGLZFNFY-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 2
- 239000003570 air Substances 0.000 description 2
- 239000012080 ambient air Substances 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000005266 casting Methods 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000010528 free radical solution polymerization reaction Methods 0.000 description 2
- QABLOFMHHSOFRJ-UHFFFAOYSA-N methyl 2-chloroacetate Chemical compound COC(=O)CCl QABLOFMHHSOFRJ-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- IAXXETNIOYFMLW-UHFFFAOYSA-N (4,7,7-trimethyl-3-bicyclo[2.2.1]heptanyl) 2-methylprop-2-enoate Chemical compound C1CC2(C)C(OC(=O)C(=C)C)CC1C2(C)C IAXXETNIOYFMLW-UHFFFAOYSA-N 0.000 description 1
- WYGWHHGCAGTUCH-UHFFFAOYSA-N 2-[(2-cyano-4-methylpentan-2-yl)diazenyl]-2,4-dimethylpentanenitrile Chemical compound CC(C)CC(C)(C#N)N=NC(C)(C#N)CC(C)C WYGWHHGCAGTUCH-UHFFFAOYSA-N 0.000 description 1
- VCYCUECVHJJFIQ-UHFFFAOYSA-N 2-[3-(benzotriazol-2-yl)-4-hydroxyphenyl]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 VCYCUECVHJJFIQ-UHFFFAOYSA-N 0.000 description 1
- RIWRBSMFKVOJMN-UHFFFAOYSA-N 2-methyl-1-phenylpropan-2-ol Chemical compound CC(C)(O)CC1=CC=CC=C1 RIWRBSMFKVOJMN-UHFFFAOYSA-N 0.000 description 1
- BCAIDFOKQCVACE-UHFFFAOYSA-N 3-[dimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azaniumyl]propane-1-sulfonate Chemical compound CC(=C)C(=O)OCC[N+](C)(C)CCCS([O-])(=O)=O BCAIDFOKQCVACE-UHFFFAOYSA-N 0.000 description 1
- 101800000263 Acidic protein Proteins 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920000288 Keratan sulfate Polymers 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 102000015728 Mucins Human genes 0.000 description 1
- 108010063954 Mucins Proteins 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- WYGWHHGCAGTUCH-ISLYRVAYSA-N V-65 Substances CC(C)CC(C)(C#N)\N=N\C(C)(C#N)CC(C)C WYGWHHGCAGTUCH-ISLYRVAYSA-N 0.000 description 1
- 229930003776 Vitamin B4 Natural products 0.000 description 1
- IAXXETNIOYFMLW-COPLHBTASA-N [(1s,3s,4s)-4,7,7-trimethyl-3-bicyclo[2.2.1]heptanyl] 2-methylprop-2-enoate Chemical compound C1C[C@]2(C)[C@@H](OC(=O)C(=C)C)C[C@H]1C2(C)C IAXXETNIOYFMLW-COPLHBTASA-N 0.000 description 1
- MCBSQDOGJSTPJG-UHFFFAOYSA-N [2-(bromomethyl)phenyl]-phenylmethanone Chemical compound BrCC1=CC=CC=C1C(=O)C1=CC=CC=C1 MCBSQDOGJSTPJG-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M acrylate group Chemical group C(C=C)(=O)[O-] NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000004397 blinking Effects 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229940107200 chondroitin sulfates Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000004694 iodide salts Chemical class 0.000 description 1
- 231100001032 irritation of the eye Toxicity 0.000 description 1
- 229940119545 isobornyl methacrylate Drugs 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 1
- IUBSYMUCCVWXPE-UHFFFAOYSA-N metoprolol Chemical compound COCCC1=CC=C(OCC(O)CNC(C)C)C=C1 IUBSYMUCCVWXPE-UHFFFAOYSA-N 0.000 description 1
- 229940051875 mucins Drugs 0.000 description 1
- 229940088644 n,n-dimethylacrylamide Drugs 0.000 description 1
- YLGYACDQVQQZSW-UHFFFAOYSA-N n,n-dimethylprop-2-enamide Chemical compound CN(C)C(=O)C=C YLGYACDQVQQZSW-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000009979 protective mechanism Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- YUYCVXFAYWRXLS-UHFFFAOYSA-N trimethoxysilane Chemical compound CO[SiH](OC)OC YUYCVXFAYWRXLS-UHFFFAOYSA-N 0.000 description 1
- RRHXZLALVWBDKH-UHFFFAOYSA-M trimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azanium;chloride Chemical compound [Cl-].CC(=C)C(=O)OCC[N+](C)(C)C RRHXZLALVWBDKH-UHFFFAOYSA-M 0.000 description 1
- 235000008979 vitamin B4 Nutrition 0.000 description 1
- 239000011579 vitamin B4 Substances 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29D—PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
- B29D11/00—Producing optical elements, e.g. lenses or prisms
- B29D11/00009—Production of simple or compound lenses
- B29D11/00038—Production of contact lenses
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/12—Esters of monohydric alcohols or phenols
- C08F220/14—Methyl esters, e.g. methyl (meth)acrylate
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/12—Esters of monohydric alcohols or phenols
- C08F220/16—Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms
- C08F220/18—Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms with acrylic or methacrylic acids
- C08F220/1802—C2-(meth)acrylate, e.g. ethyl (meth)acrylate
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/26—Esters containing oxygen in addition to the carboxy oxygen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/34—Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate
- C08F220/36—Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate containing oxygen in addition to the carboxy oxygen, e.g. 2-N-morpholinoethyl (meth)acrylate or 2-isocyanatoethyl (meth)acrylate
- C08F220/365—Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate containing oxygen in addition to the carboxy oxygen, e.g. 2-N-morpholinoethyl (meth)acrylate or 2-isocyanatoethyl (meth)acrylate containing further carboxylic moieties
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/52—Amides or imides
- C08F220/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
- C08F220/60—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide containing nitrogen in addition to the carbonamido nitrogen
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
- G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
- G02B1/041—Lenses
- G02B1/043—Contact lenses
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Mechanical Engineering (AREA)
- Manufacturing & Machinery (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Eyeglasses (AREA)
Abstract
Kontaktlinsenmaterial mit einem in ein HEMA- oder Sulfobetain-Basismaterial einpolymerisiertem Alkylammoniumhalogenid-Derivat als Comonomer, dadurch gekennzeichnet, dass durch Einpolymersieren eines Alkylammonium-Derivats mit der Strukturformeloderwobei R eine Methyl- oder Ethylgruppe ist, oder durch Einpolymersieren von N-Methacryloylamidopropyl-N-(4-trimethoxysilethyl)-benzyl-N,N-dimethyl-ammoniumchlorid (AMSi)ein Wassergehalt in hydratisierter Form von 50–70 Gew.-% vorliegt.A contact lens material having an alkyl ammonium halide derivative copolymerized in a HEMA or sulfobetaine base material as a comonomer, characterized in that by polymerizing an alkyl ammonium derivative having the structural formula, or wherein R is a methyl or ethyl group, or by copolymerizing N-methacryloyl amidopropyl N- ( 4-trimethoxysilethyl) -benzyl-N, N-dimethyl-ammonium chloride (AMSi) has a hydrated content of 50-70% by weight.
Description
Die Erfindung betrifft ein Kontaktlinsenmaterial nach dem Oberbegriff des Hauptanspruches. Kontaktlinsenmaterialien sollen bevorzugt einen hohen Wassergehalt, gute Sauerstoffdurchlässigkeit, ein gutes Wasserrückhalteverhalten, eine gut gleitende Oberfläche, gute optische Eigenschaften, gute Verarbeitungseigenschaften und gute mechanische Eigenschaften, wie Reißfestigkeit, besitzen. Dabei sollen die Kontaktlinsenmaterialien auch annähernd die Eigenschaften der Cornea des menschlichen Auges aufweisen.The invention relates to a contact lens material according to the preamble of the main claim. Contact lens materials should preferably have a high water content, good oxygen permeability, a good water retention behavior, a good sliding surface, good optical properties, good processing properties and good mechanical properties, such as tear resistance. The contact lens materials should also have approximately the properties of the cornea of the human eye.
Der Wassergehalt der Cornea liegt üblicherweise bei ca. 65 bis 75 Gew.-%, der auf ein außerordentlich hohes Wasserrückhaltevermögen der Cornea selbst zurückzuführen ist. Durch diese Wasserretention wird eine zu starke Abnahme der Oberflächenfeuchtigkeit in trockener Luft, wie etwa in kalter (Polar-)Luft, sowie auch in klimatisierten Räumen mit hoher Wasserverdunstung, wie etwa in Flugzeugen, vermieden. Dabei verhindert das hohe Wasserrückhaltevermögen gleichzeitig, dass die Konzentration der in der Tränenflüssigkeit gelösten Stoffe bei ansonsten hoher Verdunstung zu stark ansteigt und diese dann auskristallisieren.The water content of the cornea is usually about 65 to 75 wt .-%, which is due to an extremely high water retention capacity of the cornea itself. This retention of water prevents an excessive decrease in surface moisture in dry air, such as in cold (polar) air, as well as in air-conditioned spaces with high water evaporation, such as in airplanes. At the same time, the high water retention capacity simultaneously prevents the concentration of the substances dissolved in the tear fluid from increasing too much in the event of otherwise high evaporation and then crystallizing out.
In diesem Zusammenhang ist es bekannt, dass für das Wasserrückhaltevermögen der natürlichen Cornea Sulfoverbindungen, insbesondere Keratansulfate und Chondroitinsulfate, eine Rolle spielen.In this context it is known that sulfo compounds, in particular keratan sulfates and chondroitin sulfates, play a role in the water retention capacity of the natural cornea.
Neben der besonderen Eigenschaft des Wasserrückhaltevermögens muss die Cornea auch eine hohe Sauerstoffdurchlässigkeit aufweisen, da die Cornea auf ihrer Innenseite eine endotheliale Zellschicht besitzt, deren Sauerstoffversorgung nicht durch Gefäße, sondern aus der Umgebungsluft durch die Cornea hindurch erfolgt. Ein immerwährendes Aussetzen der Cornea mit der Umgebungsluft würde jedoch trotz ihres hohen Wasserrückhaltevermögens zu ihrem Austrocknen führen. Um dies zu vermeiden, wird die Cornea daher durch Lidschlag permanent mit einer als Tränen bezeichneten Flüssigkeit benetzt, die Proteine, Lipoproteine, Lipide und Mucine gelöst enthält.In addition to the special property of the water retention capacity, the cornea must also have a high oxygen permeability, because the cornea has on its inside an endothelial cell layer, the oxygen supply is not through vessels, but from the ambient air through the cornea. However, a constant exposure of the cornea to the ambient air would result in its drying out despite its high water retention capacity. To avoid this, the cornea is therefore permanently affected by blinking with a liquid called tears, which contains dissolved proteins, lipoproteins, lipids and mucins.
Durch die dauernde Neuzufuhr dieser Flüssigkeit und deren Verdunstung auf der Augenoberfläche müssten sich diese in der Tränenflüssigkeit gelösten Stoffe auf der Cornea ablagern und diese eintrüben. Damit dies nicht geschieht, hat die Natur Schutzmechanismen entwickelt, die jedoch noch nicht gänzlich aufgeklärt sind.Due to the constant re-supply of this liquid and its evaporation on the ocular surface, these substances dissolved in the tear fluid would have to deposit on the cornea and cloud them. In order for this not to happen, nature has developed protective mechanisms that have not yet been fully elucidated.
Es ist jedoch bekannt, dass in der Natur die Ablagerung der oben genannten Substanzen auf der Corneaoberfläche auch durch eine Betainstruktur innerhalb des Kollagens vermieden wird. Dabei enthält das Kollagen der Cornea als Aminosäuren Glycin, Prolin, Glutamin, Alanin, Arginin, Asparagin, Lysin, Leucin, Serin, Isoleucin sowie andere.However, it is known that in nature the deposition of the above-mentioned substances on the corneal surface is also avoided by a betaine structure within the collagen. The collagen of the cornea contains as amino acids glycine, proline, glutamine, alanine, arginine, asparagine, lysine, leucine, serine, isoleucine and others.
Bei der Anfertigung von Kontaktlinsen besteht deshalb die Notwendigkeit, darauf zu achten, dass die physiologischen Aufgaben der Cornea durch die auf die Cornea aufgesetzte Kontaktlinse und damit durch Abdecken eines Teilbereichs der Cornea im Wesentlichen nicht beeinträchtigt werden. Dieses kann dadurch erreicht werden, dass die Kontaktlinse annähernd die Eigenschaften der Cornea des Auges besitzt, wobei auch darauf geachtet werden muss, dass der Brechungsindex der Kontaktlinse dem Brechungsindex der Cornea von 1,37 angenähert sein sollte.When making contact lenses, it is therefore necessary to ensure that the physiological tasks of the cornea are essentially not impaired by the contact lens placed on the cornea and thus by covering a portion of the cornea. This can be achieved by having the contact lens approximately the same properties as the cornea of the eye, wherein care must also be taken that the refractive index of the contact lens should be close to the refractive index of the cornea of 1.37.
Aus der
Kontaktlinsenmaterial für Hydrogelkontaktlinsen ist beispielsweise aus der
Aufgabe der Erfindung ist es daher, ein Material für Kontaktlinsen, insbesondere für Ein-Tages-Kontaktlinsen und bis zu einen Monat getragene Hydrogel-Kontaktlinsen, anzugeben, das eine vorteilhafte Kombination der genannten Eigenschaften aufweist. Eine Herstellung im Formgussverfahren wird in einer bevorzugten Ausführungsform angestrebt.The object of the invention is therefore to provide a material for contact lenses, in particular for one-day contact lenses and up to one month worn hydrogel contact lenses, which has an advantageous combination of said properties. A production in the casting method is desired in a preferred embodiment.
Zur Lösung der Aufgabe wird erfindungsgemäß ein Material mit den Merkmalen des Anspruches 1 vorgeschlagen, dass zudem in Kontaktlinsenform mit einem Pflegemittel gereinigt werden kann, dass dasselbe Material als wasserlösliches Lösungspolymerisat enthält. To achieve the object, a material with the features of claim 1 is proposed according to the invention, that also can be cleaned in contact lens mold with a care agent that contains the same material as a water-soluble solution polymer.
Im Wesentlichen besteht die Erfindung darin, dass in das Basismaterial eines Kontaktlinsenmaterials wenigstens ein Alkylammoniumhalogenid-Derivat als Comonomer einpolymerisiert ist.In essence, the invention is that in the base material of a contact lens material at least one Alkylammoniumhalogenid derivative is copolymerized as a comonomer.
Dabei kann es sich bei dem Alkylammoniumhalogenid-Derivat um ein Alkylammoniumesterhalogenid der allgemeinen Formel oder ein Alkylammoniumamidhalogenid der allgemeinen Formel handeln, wobei R1: verzweigter oder unverzweigter, bevorzugt C2, Alken-Rest,
R2: verzweigter oder unverzweigter, bevorzugt C2-C3, Alkylen-Rest,
R3: verzweigter oder unverzweigter, bevorzugt C1-C12, Alkyl-Rest,
m: verzweigter oder unverzweigter, bevorzugt C1-C20, Alkylen-Rest,
R4: verzweigter oder unverzweigter, bevorzugt C1-C20, Alkoxycarbo- oder Phenyl- oder Alkoxysilyl-Rest
R5: Halogen
bedeutet.In this case, the alkylammonium halide derivative may be an alkylammonium ester halide of the general formula or an alkylammonium amide halide of the general formula where R1: branched or unbranched, preferably C2, alkene radical,
R 2: branched or unbranched, preferably C 2 -C 3, alkylene radical,
R 3: branched or unbranched, preferably C 1 -C 12, alkyl radical,
m: branched or unbranched, preferably C 1 -C 20, alkylene radical,
R 4: branched or unbranched, preferably C 1 -C 20, alkoxycarbo or phenyl or alkoxysilyl radical
R5: halogen
means.
Bevorzugt ist das Comonomer ein Alkyammoniumchlorid-Derivat, wobei aber auch andere Halogenide, beispielsweise Bromide oder Jodide, denkbar sind. Das Alkylammoniumchlorid-Derivat ist bevorzugt N-Carbomethoxymethyl-N-methacryloylamidopropyl-N,N-dimethylammoniumchlorid (AM1M) oder N-Carboxyethoxymethyl-N-methacryloylamidopropyl-N,N-dimethylammoniumchlorid (AM1E) oder ein anderes der im Anschluss an die Beschreibung in Tabelle 1 aufgeführten Alkylammoniumhalogenid-Derivate.The comonomer is preferably an alkylammonium chloride derivative, although other halides, for example bromides or iodides, are also conceivable. The alkylammonium chloride derivative is preferably N-carbomethoxymethyl-N-methacryloylamidopropyl-N, N-dimethylammonium chloride (AM1M) or N-carboxyethoxymethyl-N-methacryloylamidopropyl-N, N-dimethylammonium chloride (AM1E) or any of those described in the table below 1 listed alkylammonium halide derivatives.
Das Basismaterial besteht bevorzugt aus Hydroxyethylmethacrylat (HEMA) und/oder Hydroxypropylmethacrylat (HPMA) und/oder einem Sulfobetain, besonders bevorzugt N,N-Dimethyl-N-(2-methacryloyloxyethyl-N-(3-sulfopropyl)ammonium-betain (SPE), oder einem Gemisch davon.The base material preferably consists of hydroxyethyl methacrylate (HEMA) and / or hydroxypropyl methacrylate (HPMA) and / or a sulfobetaine, more preferably N, N-dimethyl-N- (2-methacryloyloxyethyl-N- (3-sulfopropyl) ammonium betaine (SPE) , or a mixture thereof.
Bevorzugt wird das erfindungsgemäße Kontaktlinsenmaterial durch Hitzepolymerisation oder durch Polymerisation mit UV-Licht hergestellt. Die aus diesem Material gefertigten Hydrogel-Kontaktlinsen sind weiterhin bevorzugt durch ein spanabhebendes Verfahren aus einem Stangenmaterial oder direkt durch Formgießen hergestellt.Preferably, the contact lens material according to the invention is produced by heat polymerization or by polymerization with UV light. The hydrogel contact lenses made of this material are furthermore preferably produced by a cutting process from a bar material or directly by casting.
Schließlich ist ein Pflegemittel für die erfindungsgemäße Hydrogel-Kontaktlinse vorgesehen, dass die erfindungsgemäßen unter Bedingungen der Lösungspolymerisation hergestellten Polymere als Lösungspolymerisat enthält.Finally, a care agent for the hydrogel contact lens according to the invention is provided which contains the polymer according to the invention prepared under conditions of solution polymerization as a solution polymer.
Die Erfindung wird im Folgenden anhand von Beispielen näher erläutert:
Ausgehend von einem zur Herstellung von Kontaktlinsen üblicherweise verwendeten Basismaterial, beispielsweise Hydroxyethylmethacrylat (HEMA) oder N,N-Dimethyl-N-(2-methacryloyloxyethyl-N-(3-sulfopropyl)ammoniumbetain (SPE), wurde ein Comonomer gesucht, das dem polymerisierten Kontaktlinsenmaterial die zur Weiterverarbeitung zur Kontaktlinse notwendigen eingangs genannten Eigenschaften verleiht.The invention is explained in more detail below with reference to examples:
Starting from a base material commonly used for producing contact lenses, for example, hydroxyethyl methacrylate (HEMA) or N, N-dimethyl-N- (2-methacryloyloxyethyl-N- (3-sulfopropyl) ammonium betaine (SPE), a comonomer was sought which polymerized Contact lens material gives the necessary for further processing to the contact lens properties mentioned above.
Überraschenderweise wurde gefunden, dass sich Cholinchlorid als Ausgangsmaterial zur Herstellung von Hydrogelmaterial eignet. Cholinchlorid ist eine hygroskopische Substanz, die in kristalliner Form als weißes Pulver vorliegt und in Wasser und in polaren organischen Lösungsmitteln, wie z. B. Methanol, Ethanol, Dimethylformamid, löslich ist. Cholinchlorid ist in der Physiologie auch als Vitamin B4 und wird vor allem als Futtermittelzusatz, beispielsweise zur Schweinemast, eingesetzt. Für den Menschen ist eine Tageseinnahmeempfehlung nicht festgelegt, da es zumeist ausreichend mit der Nahrung zugeführt wird.Surprisingly, it has been found that choline chloride is suitable as a starting material for the production of hydrogel material. Choline chloride is a hygroscopic substance which is present in crystalline form as a white powder and in water and in polar organic solvents, such. As methanol, ethanol, dimethylformamide, is soluble. Choline chloride is also known in the physiology as vitamin B4 and is mainly called Feed additive used, for example for pig fattening. For humans, a daily intake recommendation is not fixed, since it is usually supplied with sufficient food.
Aufgrund seiner physiologischen Unbedenklichkeit, seiner guten Wasserlöslichkeit und seiner hygroskopischen Eigenschaft besitzt Cholinchlorid gegenüber den bekannten toxischen, flüssigen Monomeren, wie beispielsweise N-Vinyl-2-pyrrolidinon oder N,N-Dimethylacrylamid gute Voraussetzungen zum Einsatz in Kontaktlinsen.Due to its physiological harmlessness, its good solubility in water and its hygroscopic property, choline chloride has good conditions for use in contact lenses in comparison with the known toxic, liquid monomers, such as, for example, N-vinyl-2-pyrrolidinone or N, N-dimethylacrylamide.
Problematisch erschien zunächst allerdings, dass zur Herstellung eines als Kontaktlinsenmaterials geeigneten Polymers eine vinyloge Doppelbindung in das Cholinmolekül eingeführt werden muss ohne dessen Struktur im Wesentlichen zu verändern. Insbesondere muss die Ammoniumstruktur erhalten bleiben, um die Wechselwirkung zwischen dem Polymer und Wasser zu erhalten.However, the problem initially appeared to be that a vinylogous double bond must be introduced into the choline molecule without substantially altering its structure in order to produce a polymer suitable as a contact lens material. In particular, the ammonium structure must be retained to maintain the interaction between the polymer and water.
Prinzipiell wurde hierzu speziell auf die in der
Es wurde dabei gefunden, dass die so hergestellten Alkylammoniumchloride sehr gut in HEMA löslich sind und nach den bekannten Methoden zu Formguss-Kontaktlinsen und Stangen verarbeitet werden können. Vorteilhaft erwies sich bei dieser Methode auch, dass die Ausgangsprodukte relativ billig sind und die Ausbeute des Reaktionsprodukts sehr gut ist.It was found that the alkyl ammonium chlorides thus prepared are very soluble in HEMA and can be processed by the known methods to cast molded contact lenses and rods. It has also proved advantageous in this method that the starting materials are relatively cheap and the yield of the reaction product is very good.
Zur Polymerisierung wurden die bereits in Tabelle 1 erwähnten, beispielhaft aufgeführten Alkylammoniumchloride verwendet, die entsprechend der nachstehend für das Alkylammoniumchlorid AM1M beispielhaft aufgeführten Anleitung aus den in der Tabelle mit A und B bezeichneten Ausgangsstoffen synthetisiert wurden.The polymerization was carried out using the alkylammonium chlorides already mentioned in Table 1, which were synthesized from the starting materials indicated in the table A and B according to the instructions exemplified below for the alkylammonium chloride AM1M.
Das Alkylammoniumchlorid AM1M wird aus dem Ausgangsstoff A: Methacrylsäure-(3-dimethylaminopropylamid) und dem Ausgangssstoff B: Chloressigsäuremethylester dargestellt. Hierzu werden 17,03 g (entspricht 0,1 Mol) Methacrylsäure-(3-dimethylaminopropylamid) [MW 170,25] in 40 ml Aceton gelöst und mit einer Lösung aus 11,94 g (entspricht 0,11 Mol) Chloressigsäuremethylester [MW 108,52] in 20 ml Aceton unter starkem Rühren bei Raumtemperatur versetzt. Die über Nacht ausgefallenen Kristalle werden dreimal mit Aceton p. A. gewaschen und im Vakuum bei 30°C getrocknet. Das so entstandene Produkt AM1M (N-Carbomethoxymethyl-N-methacryloylamidopropyl-N,N-dimethylammoniumchlorid) wird bis zur weiteren Verarbeitung im Exsikkator über Calciumchlorid aufbewahrt.The alkylammonium chloride AM1M is prepared from the starting material A: methacrylic acid (3-dimethylaminopropylamide) and the starting material B: chloroacetic acid methyl ester. For this purpose, 17.03 g (corresponding to 0.1 mol) of methacrylic acid (3-dimethylaminopropylamide) [MW 170.25] are dissolved in 40 ml of acetone and treated with a solution of 11.94 g (corresponding to 0.11 mol) of methyl chloroacetate [MW 108.52] in 20 ml of acetone with vigorous stirring at room temperature. The overnight precipitated crystals are washed three times with acetone p. A. and dried in vacuo at 30 ° C. The resulting product AM1M (N-carbomethoxymethyl-N-methacryloylamidopropyl-N, N-dimethylammonium chloride) is stored in the desiccator over calcium chloride until further processing.
Alle Alkylammoniumchloride konnten mit einer Ausbeute größer als 90% des theoretischen Wertes hergestellt werden. Bei allen Alkylammoniumchloriden handelt es sich um feste (kristalline) Substanzen, die in bekannten flüssigen Monomeren gelöst unkritisch in der Hitze polymerisiert werden konnten.All alkylammonium chlorides could be prepared with a yield greater than 90% of the theoretical value. All alkylammonium chlorides are solid (crystalline) substances which could be polymerized uncritically in the heat when dissolved in known liquid monomers.
Zur Herstellung des Kontaktlinsenmaterials wurden neben einem Alkylammoniumhalogenid beispielsweise eine oder mehrere der Substanzen 2-Hydroxyethymethacrylat (HEMA), Ethylenglycoldimethacrylat (EGA), 2-(2'-Hydroxy-5'-methacryloyloxyethylphenyl)-2H-benzotriazol (UVA), Isobornylmethacrylat (IBMA), 2,2'-Azobis-(2,4-dimethylvaleronitril) (V-65), 2,2'-Azobis-(2-methylbutyronitril) (V59) und Poly-(ethylenglykol)-methacrylat (Poly-glykol-MA) den entsprechenden Produktionsansätzen entnommen und entweder zu Stangenmaterial oder direkt zu Kontaktlinsen verarbeitet. Beispielsweise bestand ein Produktionsansatz aus 83,7 Gew.-% HEMA, 15 Gew.-% AM2E, 0,4 Gew.-% EGA, 0,5 Gew.-% UVA und 0,4 Gew.-% V65.For the preparation of the contact lens material, in addition to an alkylammonium halide, for example, one or more of 2-hydroxyethymethacrylate (HEMA), ethylene glycol dimethacrylate (EGA), 2- (2'-hydroxy-5'-methacryloyloxyethylphenyl) -2H-benzotriazole (UVA), isobornyl methacrylate (IBMA ), 2,2'-azobis (2,4-dimethylvaleronitrile) (V-65), 2,2'-azobis (2-methylbutyronitrile) (V59) and poly (ethylene glycol) methacrylate (polyglycol) MA) taken from the corresponding production approaches and either processed into bar stock or directly to contact lenses. For example, a production batch was 83.7 weight percent HEMA, 15 weight percent AM2E, 0.4 weight percent EGA, 0.5 weight percent UVA, and 0.4 weight percent V65.
Zur Herstellung von Stangenmaterial wurden Röhrchen aus Polypropylen (PP-natur, 16 × 13 mm, 235 mm; Fa. Gehr) mit einer Füllmenge von 16 g pro Rohr beladen. Nach dem Füllen wurden die Röhrchen mit Stickstoff für 10 Minuten begast und anschließend die Polymerisation mit folgendem Temperatur-/Zeit-Programm durchgeführt: 45°C/24 h; 60°C/24 h; 90°C/24 h. Nach deren Entformung wurden die Stangen bei 90°C/24 h getempert.Polypropylene (PP natural, 16 × 13 mm, 235 mm, Gehr) tubes were loaded with 16 g per tube to produce rod material. After filling, the tubes were sparged with nitrogen for 10 minutes and then the polymerization was carried out with the following temperature / time. Program carried out: 45 ° C / 24 h; 60 ° C / 24 h; 90 ° C / 24 h. After demolding, the rods were annealed at 90 ° C / 24 h.
Zur direkten Herstellung von Kontaktlinsen wurde der Reaktionsansatz in Polypropylen-Förmchen eingefüllt und die Kontaktlinse während einer Stunde bei 100°C abgeformt. Die Polymerisation kann jedoch auch mit UV-Licht (λ = 300–400 nm, 3–6 mW/cm2, für 3 Stunden bei Raumtemperatur) beispielsweise mit Darocur 1173 (Ciba-Geigy Corp.) als Photoinitiator durchgeführt werden. Die Monomermenge betrug durchschnittlich 70 μl pro Förmchen. Die Quellung erfolgte in physiologischer Kochsalzlösung unter Sterilisationsbedingungen (121°C während 20 min).For the direct production of contact lenses, the reaction mixture was filled in polypropylene molds and molded the contact lens for one hour at 100 ° C. However, the polymerization can also be carried out with UV light (λ = 300-400 nm, 3-6 mW / cm 2 , for 3 hours at room temperature) for example with Darocur 1173 (Ciba-Geigy Corp.) as photoinitiator. The amount of monomer averaged 70 μl per mold. The swelling was carried out in physiological saline under sterilization conditions (121 ° C for 20 min).
Das erfindungsgemäße Kontaktlinsenmaterial besitzt die im Folgenden für AM1E beispielhaft gezeigte Struktur: The contact lens material according to the invention has the structure shown by way of example below for AM1E:
Das Kontaktlinsenmaterial ist physiologisch gesehen als Polymer nicht toxisch. Die Extraktion von nicht polymerisierten Restmonomeren aus dem Kontaktlinsenmaterial gestaltet sich einfach, da die verwendeten Monomere voll wasserlöslich sind.The contact lens material is physiologically non-toxic as a polymer. The extraction of unpolymerized residual monomers from the contact lens material is easy, since the monomers used are fully water-soluble.
Bevorzugt können weitere Monomere oder auch Copolymere in das Basismaterial einpolymerisiert sein. Dieses sind zum einen UV-absorbierende Substanzen. Erfindungsgemäße Kontaktlinsen, die beispielsweise mit 0,5 Gew.-% UV-Absorber ausgerüstet sind, eine Lichttransmission von 2% UVB, 8% UVA und 98% sichtbarem Licht. Zum anderen besteht die Möglichkeit Substanzen mit bakterizider und/oder fungizider Wirkung einzupolymerisieren. Beispielsweise könnte hierzu ein bereits bei der Medikamentenherstellung eingesetzter Hilfsstoff (MetoHEXAL/Hexal) als Copolymeres, das u. a. aus N-Methacryloyloxyethyl-N,N,N-trimethylammoniumchlorid hergestellt wird, Verwendung finden: Poly(ethylacrylat-co-methylmethacrylat-co-2-trimethylammonioethyl)methacrylatchlorid Preferably, further monomers or else copolymers can be copolymerized into the base material. These are on the one hand UV-absorbing substances. Inventive contact lenses, which are equipped, for example, with 0.5 wt .-% UV absorber, a light transmission of 2% UVB, 8% UVA and 98% visible light. On the other hand, it is possible to polymerize substances having a bactericidal and / or fungicidal action. For example, an excipient (MetoHEXAL / Hexal) already used in the manufacture of medicaments could be used as copolymer, which is prepared, inter alia, from N-methacryloyloxyethyl-N, N, N-trimethylammonium chloride. methacrylate chloride poly (ethyl acrylate-co-methyl methacrylate-co-2-trimethylammonioethyl)
Als weiteres Beispiel könnte sich auch die bakterizide und fungizide Wirkung durch das copolymerisierte AMB ergeben, dessen Monomerstruktur dem bereits in Pflegemitteln als Bakterizid verwendetem Benzalkoniumchlorid ähnlich ist: As a further example, the bactericidal and fungicidal action could also result from the copolymerized AMB, the monomer structure of which is similar to the benzalkonium chloride already used in care products as a bactericide:
Der Vorteil von in das Kontaktlinsenmaterial polymerisierten funktionellen Gruppen mit bakterizider und/oder fungizider Wirkung besteht darin, dass die Wahrscheinlichkeit eines Bewuchses der erfindungsgemäßen Kontaktlinse mit (pathogenen) Organismen dauerhaft und von Anfang an verringert ist. Damit verbunden ist auch, dass die Kontaktlinsen nicht mehr intensiv mit Reinigungslösungen gereinigt werden müssen, die oftmals in der Kontaktlinsenmatrix verbleiben und beim Tragen der Kontaktlinse zu einer Reizung des Auges führen.The advantage of bactericidal and / or fungicidal functional groups polymerized in the contact lens material is that the likelihood of fouling of the contact lens according to the invention with (pathogenic) organisms is reduced permanently and from the beginning. This also means that the contact lenses no longer need to be intensively cleaned with cleaning solutions, which often remain in the contact lens matrix and lead to irritation of the eye when the contact lens is worn.
Die aus dem erfindungsgemäßen Kontaktlinsenmaterial gefertigte erfindungsgemäße Hydrogel-Kontaktlinse besitzt in hydratisierter Form einen Wassergehalt über 50 Gew.-%, bevorzugt zwischen 54 und 70 Gew.-%, mit gegenüber bekannten Hydrogel-Kontaktlinsen verbessertem Wasserrückhalteverhalten. Besonders vorteilhaft ist auch, dass sich die Oberfläche der Kontaktlinsen seifig anfühlt und damit zu einem angenehmen Tragegefühl beiträgt. Dabei ist die Kontaktlinse gleichzeitig äußerst reißfest und auch Hitze-sterilisierbar.The hydrogel contact lens according to the invention made of the contact lens material according to the invention has in hydrated form a water content of more than 50% by weight, preferably between 54 and 70% by weight, with improved water retention behavior compared to known hydrogel contact lenses. It is also particularly advantageous that the surface of the contact lenses feels soapy and thus contributes to a pleasant wearing feeling. At the same time, the contact lens is extremely tear-resistant and heat-sterilizable.
Ein besonderer Vorteil des erfindungsgemäßen Kontaktlinsenmaterials ist, dass es sich dabei im Gegensatz zu den bekannten anionischen Kontaktlinsenmaterialien um kationische Polymere handelt. Im physiologischen pH-Wertebereich kann das Halogenid-Ion nämlich nicht abgespalten und durch andere Anionen (z. B. saure Proteine) ersetzt werden. Damit aber bleiben die Eigenschaften der Kontaktlinse konstant. So könnte beispielsweise eine Veränderung der Quellung oder eine verstärkte Adsorptionsfähigkeit des Kontaktlinsenmaterials für Proteine erst durch Behandlung mit einer 2n Natronlauge (pH > 12) erreicht werden, da erst bei diesem pH-Wert die OH–-Form des Alkylammoniumhalegonids, das Salz einer schwachen Base und einer starken Säure ist, erhalten wird.A particular advantage of the contact lens material according to the invention is that in contrast to the known anionic contact lens materials, they are cationic polymers. Namely, in the physiological pH range, the halide ion can not be split off and replaced by other anions (eg, acidic proteins). But this keeps the properties of the contact lens constant. Thus, for example, a change in the swelling or an increased adsorption capacity of the contact lens material for proteins could only be achieved by treatment with a 2N sodium hydroxide solution (pH> 12) since it is only at this pH that the OH - form of the alkylammonium halide, the salt of a weak base and a strong acid is obtained.
Das erfindungsgemäße Kontaktlinsenmaterial kann auch als Silicon-Hydrogel Verwendung finden (siehe Tabelle 1: AMSi). Hierzu ist die Substitution einer Alkylgruppe des Ammoniumsalzes (Ammoniumchlrid, -jodid, -bromid etc.) durch eine Silicium-haltige organische Verbindung, z. B. Trimethoxysilan-(m,p-chlormethyl)-phenylethan, notwendig. Mit einer derartigen Substanz wird ein „multifunktionelles Monomer” erhalten, mit dem sowohl der Wassergehalt, der über die Ammoniumfunktion vorgegeben ist, als auch die Sauerstoffdurchlässigkeit (Dk-Wert) einzustellen ist, die durch den Siliciumgehalt des Polymers geregelt wird.The contact lens material according to the invention can also be used as silicone hydrogel (see Table 1: AMSi). For this purpose, the substitution of an alkyl group of the ammonium salt (ammonium chloride, iodide, bromide, etc.) by a silicon-containing organic compound, for. B. trimethoxysilane (m, p-chloromethyl) -phenylethane, necessary. With such a substance, a "multifunctional monomer" is obtained, with which both the water content, which is determined by the ammonium function, and the oxygen permeability (Dk value), which is controlled by the silicon content of the polymer.
Außerdem ist der Einsatz von Silicium-haltigen Ammoniumsalzen für die Einstellung der hydrophilen Oberfläche von RGP(Rigid Gas Permeable)-Kontaktlinsen vorteilhaft. Im Gegensatz zur derzeit eingesetzten Methacrylsäure enthält das erfindungsgemäße hydrophile Monomer Silicium und erhöht dadurch neben der Hydrophilität, den Dk-Wert des Materials.In addition, the use of silicon-containing ammonium salts is advantageous for adjusting the hydrophilic surface of RGP (Rigid Gas Permeable) contact lenses. In contrast to the currently used methacrylic acid, the hydrophilic monomer according to the invention contains silicon and thereby increases, in addition to the hydrophilicity, the Dk value of the material.
Schließlich können die erfindungsgemäßen Polymere auch unter Bedingungen der Lösungspolymerisation als wasserlösliche Substanzen hergestellt und in Form eines Kontaktlinsen-Pflegemittels angeboten werden. Die Kontaktlinsen würden während der Pflege mit einer gleitfähigen Schicht überzogen und gleichzeitig bevorzugt durch ein makromolekulares Desinfektionsmittel, das nicht in die Kontaktlinsenmatrix eindringen kann, keimfrei gemacht.Finally, the polymers of the invention can also be prepared under conditions of solution polymerization as water-soluble substances and offered in the form of a contact lens care product. The contact lenses would be coated with a lubricious layer during care and, at the same time, preferably germ-free by a macromolecular disinfectant that can not penetrate the contact lens matrix.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102006004111.9A DE102006004111B4 (en) | 2006-01-28 | 2006-01-28 | Contact lens material |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102006004111.9A DE102006004111B4 (en) | 2006-01-28 | 2006-01-28 | Contact lens material |
Publications (2)
Publication Number | Publication Date |
---|---|
DE102006004111A1 DE102006004111A1 (en) | 2007-08-09 |
DE102006004111B4 true DE102006004111B4 (en) | 2015-11-19 |
Family
ID=38281979
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE102006004111.9A Active DE102006004111B4 (en) | 2006-01-28 | 2006-01-28 | Contact lens material |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE102006004111B4 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110097277A1 (en) | 2005-08-25 | 2011-04-28 | University Of Washington | Particles coated with zwitterionic polymers |
EP1924654B1 (en) | 2005-08-25 | 2020-05-06 | University of Washington | Super-low fouling sulfobetaine and carboxybetaine materials and related methods |
EP2069412B1 (en) | 2006-08-07 | 2019-01-02 | University of Washington | Mixed charge copolymers and hydrogels |
EP2104846A2 (en) | 2006-12-29 | 2009-09-30 | The University of Washington | Dual-functional nonfouling surfaces and materials |
US8658192B2 (en) | 2007-11-19 | 2014-02-25 | University Of Washington | Integrated antimicrobial and low fouling materials |
JP2011503332A (en) * | 2007-11-19 | 2011-01-27 | ユニヴァーシティ オブ ワシントン | Ship coating |
US9533006B2 (en) | 2007-11-19 | 2017-01-03 | University Of Washington | Marine coatings |
MX2010005295A (en) | 2007-11-19 | 2010-06-23 | Univ Washington | Cationic beataine precursors to zwitterionic betaines having controlled biological properties. |
CA2745204C (en) | 2008-12-05 | 2017-01-03 | Semprus Biosciences Corp. | Layered non-fouling, antimicrobial, antithrombogenic coatings |
KR20130000369A (en) | 2009-09-25 | 2013-01-02 | 오리진 테크놀로지스 인코포레이티드 | Protein arrays and uses thereof |
JP2013510229A (en) | 2009-11-06 | 2013-03-21 | ユニヴァーシティ・オブ・ワシントン・スルー・イッツ・センター・フォー・コマーシャリゼーション | Self-assembled particles from zwitterionic polymers and related methods |
JP5868862B2 (en) | 2009-11-06 | 2016-02-24 | ユニヴァーシティ・オブ・ワシントン・スルー・イッツ・センター・フォー・コマーシャリゼーション | Zwitterionic polymer bioconjugates and related methods |
CA2872378C (en) | 2011-07-20 | 2016-01-12 | University Of Washington Through Its Center For Commercialization | Photonic blood typing |
US9000063B2 (en) | 2011-12-14 | 2015-04-07 | Semprus Biosciences Corporation | Multistep UV process to create surface modified contact lenses |
WO2013090813A1 (en) | 2011-12-14 | 2013-06-20 | Semprus Biosciences Corp. | Redox processes for contact lens modification |
MX2014007211A (en) | 2011-12-14 | 2015-04-14 | Semprus Biosciences Corp | Silicone hydrogel contact lens modified using lanthanide or transition metal oxidants. |
CA2858730C (en) | 2011-12-14 | 2017-07-18 | Semprus Biosciences Corp. | Surface modified contact lenses |
WO2013115917A1 (en) | 2011-12-14 | 2013-08-08 | Semprus Biosciences Corp. | Imbibing process for contact lens surface modification |
US10031138B2 (en) | 2012-01-20 | 2018-07-24 | University Of Washington Through Its Center For Commercialization | Hierarchical films having ultra low fouling and high recognition element loading properties |
US20210268003A1 (en) * | 2018-06-26 | 2021-09-02 | Seed Co., Ltd. | Anionic drug-containing ophthalmic device |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4463149A (en) * | 1982-03-29 | 1984-07-31 | Polymer Technology Corporation | Silicone-containing contact lens material and contact lenses made thereof |
US4472327A (en) * | 1983-01-31 | 1984-09-18 | Neefe Charles W | Method of making hydrogel cosmetic contact lenses |
EP0076136B1 (en) * | 1981-09-28 | 1989-09-20 | Alcon Laboratories, Inc. | Ophthalmic solutions |
US20050080245A1 (en) * | 2003-10-08 | 2005-04-14 | Hung William M. | Water-soluble chitosan having low endotoxin concentration and methods for making and using the same |
-
2006
- 2006-01-28 DE DE102006004111.9A patent/DE102006004111B4/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0076136B1 (en) * | 1981-09-28 | 1989-09-20 | Alcon Laboratories, Inc. | Ophthalmic solutions |
US4463149A (en) * | 1982-03-29 | 1984-07-31 | Polymer Technology Corporation | Silicone-containing contact lens material and contact lenses made thereof |
US4472327A (en) * | 1983-01-31 | 1984-09-18 | Neefe Charles W | Method of making hydrogel cosmetic contact lenses |
US20050080245A1 (en) * | 2003-10-08 | 2005-04-14 | Hung William M. | Water-soluble chitosan having low endotoxin concentration and methods for making and using the same |
Also Published As
Publication number | Publication date |
---|---|
DE102006004111A1 (en) | 2007-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE102006004111B4 (en) | Contact lens material | |
DE69839054T2 (en) | BIOMIMETRIC MATERIALS OF THE HYDROGEL TYPE | |
DE69828993T2 (en) | CONTROLLED DELIVERY OF PHARMACEUTICALS IN THE FRONT EYE CHAMBER | |
DE2364675C2 (en) | Copolymer consisting of a polymer main chain and polymer side chains and its use for the manufacture of articles for biomedical purposes | |
EP2199834B1 (en) | Ophthalmological composition and ophthalmologic lens | |
DE69929798T2 (en) | ULTRAVIOLETTE RADIATES BLOCKING LENSES AND BENZOTRIAZOL AND BENZOPHENONE CONTAINING MATERIALS | |
EP0938511B1 (en) | Polymers with anti-microbial properties | |
EP2225293B1 (en) | Copolymer and ophthalmological composition | |
DE69920292T2 (en) | SUITABLE MATERIALS FOR THE PRODUCTION OF INTRAOCULAR LENSES | |
DE60315322T2 (en) | COMPOSITIONS WITH IMPROVED ANTIMICROBIAL EFFICACY AGAINST ACANTHAMOEBAE | |
EP1205773B1 (en) | Hydrogel contact lenses with improved biocompatibility | |
DE60107461T2 (en) | USE OF CATIONIC POLYSACCHARIDES FOR THE PREVENTION OF BACTERIAL APPLICATIONS | |
JP4379778B2 (en) | Drug sustained-release ophthalmic lens | |
WO2012025582A2 (en) | Method for producing highly concentrated solutions of self-assembling proteins | |
EP2034933B1 (en) | Ophthalmological composition and use thereof | |
EP0343996A2 (en) | Ultraviolet absorbing hydrogels | |
DE19646965C2 (en) | Acrylate-based biophobic polymers, processes for their production and their use | |
DE602005004916T2 (en) | NEW PREPOLYMERS FOR IMPROVED SURFACE CHANGE OF CONTACT LENSES | |
US20100069544A1 (en) | Hydrogel contact lens comprising a polymer comprising a carboxy betaine ester monomer | |
DE60117373T2 (en) | USE OF OPHTHALMIC COMPOSITIONS WITH LOW ION STRENGTH | |
DE102017222072B4 (en) | Article containing a hydrogel with antioxidant properties | |
DE69828451T2 (en) | AQUEOUS OPHTHALMIC FORMULATIONS WITH CHITOSAN | |
DE60014114T2 (en) | METHOD FOR PRODUCING NETWORKED, TRANSPARENT, HYDROPHILIC AND PHOTOCHROMIC PLASTIC MATERIALS AND OPTICAL AND OPTHALMIC OBJECTS | |
EP0115633A1 (en) | Hydrophilic cellulose-ester, process for the preparation and the use in biomedical materials and contact lenses made therefrom | |
JPH08311045A (en) | Beztriazole compound, ultraviolet absorbing agent therefrom and lenz for eyeglass containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
OP8 | Request for examination as to paragraph 44 patent law | ||
R016 | Response to examination communication | ||
R016 | Response to examination communication | ||
R018 | Grant decision by examination section/examining division | ||
R020 | Patent grant now final | ||
R082 | Change of representative |
Representative=s name: LOBEMEIER, MARTIN LANDOLF, DR., DE |